Out-of-Pocket Payment

Older adults with behavioral health disorders often experience worse health and functional outcomes, have higher rates of emergency department visits, use more medications, and have higher health care costs than those without a behavioral health disorder. There is need for a greater understanding of the extent to which older adults experience behavioral health disorders.

Biosimilars provide competition for biologics, which account for a significant and growing portion of Medicare Part B drug spending. This report evaluates the current state of biosimilar competition in Medicare Part B and explores opportunities to achieve further savings.

The Inflation Reduction Act (IRA) will make key changes to improve drug affordability for people who have Medicare.

This Brief presents information about the risk of needing care and associated costs to provide content for policymakers and others considering long-term care financing proposals. It revises a brief that was written in October 2020.

This study was conducted in response to a requirement in the Health Information Technology for Economic and Clinical Health Act (HITECH Act) which directs the Secretary to examine certain issues and determine the extent to which and manner in which payment incentives and other funding for implementing and using certified EHR technology should be made available to health care providers who are r

This interim report is in response to the Health Information Technology for Economic and Clinical Health Act of the American Recovery and Reinvestment Act of 2009 (Pub. L. 111-5).

The Medicare and Medicaid programs distribute extra payments to hospitals that treat a disproportionate share of indigent patients. The disproportionate share hospital (DSH) payment policies differ substantially between the two programs and, under Medicaid, across states as well.